Outcomes summary

Review summarizing clinical evidence for tesamorelin in HIV-associated lipodystrophy, including effects on visceral adiposity and related metabolic measures.

Limitations

Review article; conclusions depend on included study quality and publication context.

Notes

Primary source: PMID 21668043.